Ligand Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.About LGND
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.
CEOTodd Christopher Davis
CEOTodd Christopher Davis
Employees68
Employees68
HeadquartersJupiter, Florida
HeadquartersJupiter, Florida
Founded1987
Founded1987
Employees68
Employees68
LGND Key Statistics
Market cap3.74B
Market cap3.74B
Price-Earnings ratio93.94
Price-Earnings ratio93.94
Dividend yield—
Dividend yield—
Average volume197.86K
Average volume197.86K
High today$195.30
High today$195.30
Low today$188.66
Low today$188.66
Open price$195.30
Open price$195.30
Volume204.46K
Volume204.46K
52 Week high$212.49
52 Week high$212.49
52 Week low$93.58
52 Week low$93.58
Stock Snapshot
With a market cap of 3.74B, Ligand Pharmaceuticals(LGND) trades at $190.20. The stock has a price-to-earnings ratio of 93.94.
During the trading session on 2025-12-30, Ligand Pharmaceuticals(LGND) shares reached a daily high of $195.30 and a low of $188.66. At a current price of $190.20, the stock is +0.8% higher than the low and still -2.6% under the high.
Trading volume for Ligand Pharmaceuticals(LGND) stock has reached 204.46K, versus its average volume of 197.86K.
Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $212.49 and a low of $93.58.
Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $212.49 and a low of $93.58.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.